proved much more successful. A biological screening within the class of indol-3-ylglyoxylamides 1−3 allowed us to identify compounds 1c and 2b as potential anxiolytic/nonsedative agents showing α2 selective efficacy in vitro and anxioselective effects in vivo. According to molecular modeling studies, and consistently with SARs accumulated in the past decade, 5-NO2− and 5-H-indole derivatives would
Anxioselective剂可以化合物选择性结合中被识别的α 2 β X γ 2的γ
氨基
丁酸A(
GABA的亚型甲)/中枢苯并二氮杂受体(
BZR)配合物和表现为激动剂或化合物与相当的效力结合间各种亚型
BZR而是仅在α引发激动2 β X γ 2受体。由于
BZR亚型之间存在细微的空间差异,因此后一种方法已被证明更为成功。类
吲哚-3- ylglyoxylamides内的
生物筛选1 - 3使我们能够确定化合物1C和2B作为潜在的抗焦虑/ nonsedative剂表示α 2选择性功效在体外和体内anxioselective效果。根据分子模型研究,与过去十年中积累的
SAR一致,5-NO 2-和5-H-
吲哚衍
生物会通过将
吲哚环置于L Di和L 2受体结合位点而优先与
BZR结合,分别。